Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03475173 · ClinicalTrials.gov registry record · NA
New Non-invasive Modalities for Assessing Retinal Structure and Function
A NA study of Hemianopia and Leber Hereditary Optic Neuropathy, sponsored by Randy Kardon.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT03475173: Recruiting NA study of Hemianopia and Leber Hereditary Optic Neuropathy, sponsored by Randy Kardon.
NCT03475173 is a NA study of Hemianopia and Leber Hereditary Optic Neuropathy that is actively recruiting participants, run by Randy Kardon. The registered enrollment target is 500 participants, above the 63-participant average among 6 other Hemianopia trials with a reported enrollment target (694% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03475173, a NA study of Hemianopia and Leber Hereditary Optic Neuropathy, is actively recruiting participants, sponsored by Randy Kardon.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study investigates a new technology to assess the structure and function inside the eye. Retinal imaging of subjects with inner and outer retinal defects to detect areas of abnormal structure and function compared to other visual function tests.
Primary Outcome
imaging the movement of blood through blood vessels in retina and optic nerve
Conditions Studied
Interventions
- DEVICE LSFG-NAVI
Study Locations (1)
Iowa
- University of Iowa Department of Ophthalmology - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2019-05-06 |
| Est. Completion | 2028-03-01 |
| Phase | NA |
What NCT03475173 shows while recruiting
NCT03475173 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 63-participant average among 6 other Hemianopia trials with a reported enrollment target (694% higher).
The record links to 5 conditions, with Hemianopia appearing as the primary indexed condition, and to 1 intervention - of which LSFG-NAVI is the first listed.
NCT03475173 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT03475173 about?
NCT03475173 is a clinical study titled "New Non-invasive Modalities for Assessing Retinal Structure and Function". This study investigates a new technology to assess the structure and function inside the eye. Retinal imaging of subjects with inner and outer retinal defects to detect areas of abnormal structure and function compared to other visual function tests.
What is the current status of trial NCT03475173?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2019-05-06. Estimated completion is 2028-03-01.
What conditions does trial NCT03475173 study?
This clinical trial studies the following conditions: Hemianopia, Leber Hereditary Optic Neuropathy, Ischemic Optic Neuropathy, Branch Retinal Artery Occlusion, Acute Zonal Occult Outer Retinopathy.
What interventions are being tested in trial NCT03475173?
The interventions under investigation include: LSFG-NAVI (DEVICE).
Who is sponsoring clinical trial NCT03475173?
This trial is sponsored by Randy Kardon, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03475173 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemianopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Vision Loss Impact on Navigation in Virtual Reality
RECRUITING · NA
-
Visual Plasticity Following Brain Lesions
RECRUITING · NA
-
Effect of Visual Retraining After Stroke
RECRUITING · NA
-
Visual Rehabilitation After Occipital Stroke
ACTIVE NOT RECRUITING · NA
-
Visual Restoration for Hemianopia
COMPLETED · NA
-
Mechanisms of Visual Restoration After Occipital Stroke
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI